Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open‐Label, Active‐Treatment Extension Study

Author:

Brunner Hermine I.1ORCID,Quartier Pierre2,Alexeeva Ekaterina3,Constantin Tamàs4,Koné‐Paut Isabelle5ORCID,Marzan Katherine6,Schneider Rayfel7,Wulffraat Nico M.8,Chasnyk Vyacheslav9,Tirosh Irit10,Kallinich Tilmann11,Kuemmerle‐Deschner Jasmin12,Wouters Carine13,Lauwerys Bernard14,Nikishina Irina15,Trachana Maria16,Vougiouka Olga17,Martini Alberto18,Lovell Daniel J.1ORCID,Levy Jeremy19,Vritzali Eleni20,Ruperto Nicolino21ORCID,

Affiliation:

1. Cincinnati Children’s Hospital Medical Center and University of Cincinnati Cincinnati Ohio

2. Université de Paris Institut IMAGINE Centre de référence national pour les Rhumatismes inflammatoires et les maladies Auto‐Immunes Systémiques rares de l’Enfant Hôpital Necker‐Enfants Malades AP‐HP Paris France

3. Federal State Autonomous Institution National Medical Research Center of Children's Health of the Ministry of Health of the Russian Federation Federal State Autonomous Educational Institution of Higher Education I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation Moscow Russia

4. Semmelweis University Budapest Hungary

5. Centre de Référence des Maladies Auto‐Inflammatoires rares et des Amyloses CHU de Biĉetre AP‐HP University of Paris Sud Paris France

6. Children's Hospital of Los Angeles Los Angeles California

7. University of Toronto and Hospital for Sick Children Toronto Ontario Canada

8. Wilhelmina Children’s Hospital Utrecht The Netherlands

9. Saint‐Petersburg State Pediatric Medical University Saint‐Petersburg Russia

10. The Edmond and Lily Safra Children's Hospital Ramat Gan Israel

11. Charité University Medicine Berlin and Leibniz Institut Berlin Germany

12. University Hospital Tuebingen Tuebingen Germany

13. Universitair Ziekenhuis Leuven and Katholieke Universiteit Leuven Leuven Belgium

14. Université catholique de Louvain and Cliniques Universitaires Saint‐Luc Brussels Belgium

15. VA Nasonova Research Institute of Rheumatology Moscow Russia

16. Hippokration General Hospital and Thessaloniki University School of Medicine Thessaloniki Greece

17. P&A Kyriakou Children's Hospital and Athens University School of Medicine Athens Greece

18. Università degli Studi di Genova Genoa Italy

19. Biometrical Practice BIOP Basel Switzerland

20. Novartis Pharma Basel Switzerland

21. IRCCS Istituto Giannina Gaslini Clinica Pediatrica e Reumatologia PRINTO Genoa Italy

Funder

Novartis Pharma

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3